Cargando…
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”
Autores principales: | Capecchi, Pier Leopoldo, Lazzerini, Pietro Enea, Brillanti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098030/ https://www.ncbi.nlm.nih.gov/pubmed/33964372 http://dx.doi.org/10.1016/j.jhep.2021.04.039 |
Ejemplares similares
-
Reply to: “Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?””
por: Bril, Fernando, et al.
Publicado: (2021) -
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
por: Bril, Fernando, et al.
Publicado: (2021) -
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016) -
Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021) -
Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
por: Lazzerini, Pietro Enea, et al.
Publicado: (2018)